“opioid” Archives

in
Entry Author Date Location
“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug 10/12/20 New York
FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats 10/09/20 Europe
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data 01/14/20 National
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It? 10/10/19 National
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Nektar Forms New Company Inheris to Take Reins on Pain, CNS Drugs 05/23/19 San Francisco
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More 04/12/19 National
Trevi Therapeutics Files for IPO to Fund Anti-Itching Drug R&D 04/08/19 New York
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Pear Therapeutics App Gets FDA Nod for Treating Opioid Abuse 12/11/18 Boston
Pain Drug Race Continues as Regeneron Posts Early Phase 3 Results 08/16/18 New York
NIH Outlines $500M Plan to Develop New Pain Drugs and Fight Opioid Crisis 06/13/18 National
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More 06/01/18 National
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
FDA Refuses Review of Alkermes Depression Drug, Wants More Trials 04/02/18 Boston
At Opioid Hearing, BIO Exec Proposes Ways to Boost Pain Drug Development 03/21/18 National
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More 10/27/17 National
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Tackling Opioid Crisis, Biobot Wins Top Prize at MIT DesignX Event 05/18/17 Boston
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
Houston Biotech Vapogenix Raises $8.2M for Phase 2 Trial 12/08/16 Texas
Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 06/17/16 National
Page 1 of 1